Direct Oral Anticoagulant Drugs in Dental Clinical Practice
By:
References
- 1. Schulman S. Advantages and limitations of the new anticoagulants. J Int Med 2014; 275(1): 1-11.10.1111/joim.1213824112453
- 2. Sorensen SV, Kansal AR, Connolly S, et al. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective. J Thromb Haemost. 2011;105(5):908-19.10.1160/TH11-02-008921431243
- 3. Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361:1139-1151.10.1056/NEJMoa090556119717844
- 4. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fi brillation. N Engl J Med 2011; 365:883-891.10.1056/NEJMoa100963821830957
- 5. Cohen AT, Spiro TE, Buller HR, et al; MAGELLAN Investigators. Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 2013; 368:513-523.10.1056/NEJMoa111109623388003
- 6. Hirsh J, O'Donnell M and Weitz JY.New anticoagulants. Blood 2005; 105:453-463.10.1182/blood-2003-12-419515191946
- 7. Pradaxa 150 mg cps dur. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000829/WC500041059.pdf
- 8. Xarelto 10 mg tbl flm. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000944/WC500057108.pdf
- 9. Eliquis 5 mg tbl flm. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002148/WC500107728.pdf
- 10. Geerts B. The Role of Warfarin in the Era of New Oral Anticoagulants. The 9th International Winter Arrhythmia School, Collingwood, February 12, 2012. Available at: www.winterarrhythmia.com, [cit.2015-04-07].
- 11. Raval AN, Cigarroa JE, Chung MK. Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting. A Scientific Statement From the American Heart Association. Circulation. 2017;135(10) : e604-e633. DOI: 10.1161/CIR. 0000000000000477. Available at: http://circ.ahajournals.org/content/135/10/e604.long, [cit.2015-04-07].10.1161/CIR.000000000000049328264900
- 12. Connolly G, Spyropoulos AC. Practical issues, limitations, and periprocedural management of the NOAC’s. J Thromb Thrombolysis 2013; 36:212-222.10.1007/s11239-013-0911-223532364
- 13. vanRyn J, Stangier J, Haertter S, et al. Dabigatran etexilate - a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost 2010; 103 (6):1116-1127.10.1160/TH09-11-075820352166
- 14. Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery? Blood 2012; 120 (15):2954-2962.
- 15. Fawole A, Daw HA, Crowther MA. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban. Clev Clin J Med 2013; 80 (7):443-451.10.3949/ccjm.80a.1302523821689
- 16. UC Davis Health System Anticoagulation Services Recommendations for anticoagulation management before and after dental procedures, Approved by UCDHS Pharmacy and Therapeutics Committee 6/2015. Available at: https://www.ucdmc.ucdavis.edu/anticoag/pdf/AnticoagDentalProcedure.pdf, [cit.2015-04-07].
- 17. Ballantyne S. Guidenline for managing patients on Rivaroxaban (XareltoR), 2013, Available at: http://www.health.qld.gov.au./qhcss/mapsu/documents/dabigatran_info.pdf, [cit.2015-04-07].
- 18. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S-50S.10.1378/chest.141.4.1129b
- 19. Mingaro-De-Leon A, Chaveli-Lopez B. Alternative to oral dicoumarin anticoagulants: Consideration in dental care. Journal of clinical and experimental dentistry, 2013; 5(5):273-278.10.4317/jced.51226389226024455094
- 20. Randall C. MWMIC Medicines FAQ. New oral anticoagulants (NOACs) and management of dental pa - tients - Dabigatran, rivaroxaban and apixaban. Dental Clinical Guidance. May 2013, Updated Nov 2013. Available at: www.eryldc.co.uk, [cit.2015-04-07].
- 21. Wahl, MJ. Myths of dental surgery in patients receiving anticoagulant therapy. J Am Dent Assoc 2000; 131:77-81.10.14219/jada.archive.2000.002410649877
- 22. Israels S, Schwetz N, Boyar R, et al. Bleeding Disorders: Characterization, Dental Considerations and Management. Can Dent Assoc 2006; 72(9):827.
Language: English
Page range: 20 - 27
Submitted on: Mar 9, 2017
Accepted on: May 13, 2017
Published on: Sep 30, 2017
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Keywords:
Related subjects:
© 2017 J. Stasko, J. Stasko, M. Janickova, K. Mikuskova, I. Malachovsky, P. Gengelova, M. Kasaj, M. Smatanova, D. Statelova, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.